129
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES Platelets, Thrombosis and Hemostasis

In-Vitro Platelet Hyperaggregation and Hypersecretion Associated with the Use of Fish Oil in Healthy Children

, , , &
Pages 688-697 | Received 21 Oct 2012, Accepted 24 Nov 2012, Published online: 09 Jan 2013

REFERENCES

  • Guilliams TG. The use of fish oil supplements in clinical practice: a review. JANA. 2005;1:21–34.
  • Harris WS. Fish oil supplementation: evidence for health benefits. Cleve Clin J Med. 2004;71:208–210.
  • Harris WS, Reid KJ, Sands SA, Spertus JA. Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol. 2007;99:154–158.
  • Geelen A, Brouwer IA, Schouten EG, et al. Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. Am J Clin Nutr. 2005;81:416–420.
  • Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762–2768.
  • von Schacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554–562.
  • Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med. 1993;153:1595–1601.
  • Erkkilä AT, Lichtenstein AH, Mozaffarian D, Herrington DM. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr. 2004;80:626–632.
  • Dallongeville J, Yarnell J, Ducimetière P, et al. Fish consumption is associated with lower heart rates. Circulation. 2003;108:820–825.
  • Lovegrove JA, Lovegrove SS, Lesauvage SV, Moderate fish-oil supplementation reverses low-platelet, long-chain n-3 polyunsaturated fatty acid status and reduces plasma triacylglycerol concentrations in British Indo-Asians. Am J Clin Nutr. 2004;79:974–982.
  • Appel LJ, Miller ER III, Seidler AJ, Whelton PK. Does supplementation of diet with “fish oil” reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med. 1993;153:1429–1438.
  • Toft I, Bønaa KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial. Ann Intern Med. 1995;123:911–918.
  • Esposito K, Marfella R, Ciotola M, et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292:1440–1446.
  • Kabir M, Skurnik G, Naour N, et al. Treatment for 2 mo with n-3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr. 2007;86:1670–1679.
  • Mori TA, Bao DQ, Burke V, et al. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr. 1999;70:817–825.
  • Galarraga B, Ho M, Youssef HM, et al. Cod liver oil (n-3 fatty acids) as an nonsteroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford). 2008;47: 665–669.
  • Geusens P, Wouters C, Nijs J, et al. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum. 1994;37:824–829.
  • Belluzzi A, Brignola C, Campieri M, et al. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996;334:1557–1560.
  • Schaefer EJ, Bongard V, Beiser AS, Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006;63:1545–1550.
  • Hamazaki T, Sawazaki S, Itomura M, The effect of docosahexaenoic acid on aggression in young adults. A placebo-controlled double-blind study. J Clin Invest. 1996;97:1129–1133.
  • Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol. 2008;126:826–833.
  • Weiss LA, Barrett-Connor E, von Mühlen D. Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr. 2005;81:934–938.
  • Hogg RJ, Fitzgibbons L, Atkins C, et al. Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent. Clin J Am Soc Nephrol. 2006;1:1167–1172.
  • Kris-Etherton PM, Harris WS, Appel LJ; Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2003;23:151–152.
  • Mackay I, Ford I, Thies F, Effect of omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease. Atherosclerosis. 2012;221:514–520.
  • Opperman M, Marais de W, Spinnler Benade AJ. Analysis of omega-3 fatty acid content of South African fish oil supplements. Cardiovasc J Afr. 2011;22:324–329.
  • Woodside JV, Kromhout D. Fatty acids and CHD. Proc Nutr Soc. 2005;64:554–564.
  • Akça T, Karagöz T. Omega-3 yağ asitleri ve kalp hastalıkları. Katkı. 2006;28:78–88.
  • Agren JJ, Vaisanen S, Hanninen O, Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1997;57:419–421.
  • Mori TA, Beilin LJ, Burke V, Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997;17:279–286.
  • Vanschoonbeek K, de Maat MP, Heemskerk JW. Fish oil consumption and reduction of arterial disease. J Nutr. 2003;133:657–658.
  • Malle E, Kostner GM. Effects of fish oil on lipid variables and platelet function indices. Prostaglandins Leukot Essent Fatty Acids. 1993;49:645–663.
  • Saremi A, Arora R. The utility of omega-3 fatty acids in cardiovascular disease. Am J Ther. 2009;16:421–436.
  • Salachas A, Papadopoulos C, Sakadamis G, Effects of a low-dose fish oil concentrate on angina, exercise tolerance time, serum triglycerides, and platelet function. Angiology. 1994;45:1023–1031.
  • Phang M, Sinclair AJ, Lincz LF, Garg ML. Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation. Nutr Metab Cardiovasc Dis. 2012;22:109–114.
  • von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest. 1985;76:2446–2450.
  • Larson MK, Ashmore JH, Harris KA, Effects of omega-3 acid ethyl esters and aspirin, alone and in combination, on platelet function in healthy subjects. Thromb Haemost. 2008;100:634–641.
  • Guillot N, Caillet E, Laville M, Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 2009;23:2909–2916.
  • Mackay I, Ford I, Thies F, et al. Effect of omega-3 fatty acid supplementation on markers of platelet and endothelial function in patients with peripheral arterial disease. Atherosclerosis. 2012;221:514–520.
  • Shahar E, Folsom AR, Wu KK, Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk In Communities (ARIC) Study. Arterioscler Thromb. 1993;13:1205–1212.
  • Archer SL, Green D, Chamberlain M, Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the Coronary Artery Risk Development In Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol. 1998;18:1119–1123.
  • Marckmann P, Bladbjerg EM, Jespersen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol. 1997;17:3384–3391.
  • Johansen O, Seljeflot I, Hostmark AT, Arnesen H. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vas Biol. 1999;19:1681–1686.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.